Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Brain Neoplasms 4Pancreatic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Glioma 2Esophageal Neoplasms 2Craniopharyngioma 2Wilms Tumor 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Resectable Lung Non-Small Cell Carcinoma 1Recurrent Head and Neck Carcinoma 1Radiation Injuries 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningioma 1Gliosarcoma 1Eye Neoplasms 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

nedaplatin 1X-Rays 1Specimen Handling 1Protons 1Proton Therapy 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Resectable Lung Non-Small Cell Carcinoma × Proton Therapy × Clear all
NCT06008730 2025-11-10

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Emory University

Phase 2 Recruiting
20 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡